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A B S T R A C T
Objective: To evaluate levels of proinﬂammatory cytokines and sialidase activity in aerobic vaginitis (AV)
in relation to normal vaginal ﬂora and bacterial vaginosis (BV).
Study design: In this cross-sectional study, a total of 682 consecutive non-pregnant women attending the
gynecology service were assessed and 408 women were included. Vaginal rinsing samples were
collected from 223 women with microscopic ﬁnding of BV (n = 98), aerobic vaginitis (n = 25) and normal
ﬂora (n = 100). Samples were tested for interleukin (IL)-1b, IL-6, IL-8, tumor necrosis factor (TNF)-a, and
sialidase activity.
Results: Compared to women with normal ﬂora, vaginal levels of IL-1b were highly increased in both BV
and AV (p < 0.0001). Signiﬁcantly higher vaginal IL-6 was detected in AV (p < 0.0001) but not in BV, in
relation to normal ﬂora. Women with AV also presented increased IL-8 levels (p < 0.001), while those
with BV presented levels similar to normal ﬂora. Sialidase was increased in BV and AV compared with the
normal group (p < 0.0001) but no difference in sialidase activity was observed between BV and AV.
Conclusion: A more intense inﬂammatory host response occurs for AV than for BV when compared with
normal ﬂora. Furthermore, the increased sialidase activity in AV and BV indicates that both abnormal
vaginal ﬂora types can be harmful to the maintenance of a healthy vaginal environment.
 2012 Elsevier Ireland Ltd. 
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Abnormal vaginal ﬂora have been linked to many severe
gynecological and obstetric complications, such as pelvic inﬂam-
matory disease, increased risk of sexually transmitted diseases
(STD) and preterm birth [1–6]. Changes in vaginal ﬂora activate the
local immunity as reﬂected in the locally elevated cytokine levels
[7–9] produced by the resident monocytes/macrophages and
lymphocytes [10].
Changes in vaginal cytokine levels occur even in response even
to minor shits in the composition of the vaginal microbiota [11].
Vaginal epithelial cells express on their surfaces important
receptors for microbial recognition, such as toll-like receptors
(TLR). These receptors recognize molecular patterns present on the
bacterial surface and induce production of proinﬂammatory
cytokines through nuclear factor kappa B activation [10]. Accord-
ing to a previous study, Interleukin (IL)-1b is increased in bacterial* Corresponding author at: Department of Pathology, Botucatu Medical School,
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Open access under the Elsevier OA license.vaginosis (BV) and aerobic vaginitis (AV) [8]. In the same study,
however, the levels of IL-6 were elevated only in AV [8]. Data
regarding the neutrophil chemotactic IL-8 in BV are still conﬂicting
[9,12] and it has not been evaluated in AV.
Several studies suggest that the diversity in microbial
composition of the vaginal ﬂora, and differences in the composi-
tion of bacterial products present, is a probable cause of diversity in
the inﬂammatory response. As recently demonstrated, short chain
fatty acids produced by anaerobes in bacterial vaginosis (BV), can
interfere with the TLR-mediated inﬂammatory response [13].
Additionally, hydrolytic bacterial enzymes known as sialidases are
produced by BV-associated bacteria, such as Gardnerella vaginalis
and Prevotella bivia [14]. High sialidase levels have been considered
a risk factor for preterm birth [15,16]. Sialidase plays a role in
downregulating the innate immune system in BV, since it degrades
host defence molecules such as Immunoglobulin-A (IgA) against G.
vaginalis hemolysin [17], which can be harmful to the maintenance
of a healthy vaginal environment. Recent work demonstrated that
removal of sialic acid from secretory IgA is the mechanism by
which sialidase leads to IgA proteolysis and consequent lowered
local immune response [18]. Conﬁrming the effect of sialidase in
the vaginal ﬂora, Santiago et al. [19] reported that G. vaginalis
sialidase-producer strains have higher adherence capacity to
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of this enzyme in the pathogenesis of BV and its likelihood of
recurrence.
Considering the variability in the innate immune response to
the different types of abnormal vaginal ﬂora and the importance of
sialidase in the pathogenesis of these conditions, we aimed to
determine the sialidase proﬁle in AV, as well as to measure the
associated levels of proinﬂammatory cytokines in relation to
normal ﬂora and BV.
2. Materials and methods
In this cross-sectional study, a total of 682 consecutive,
premenopausal, non-pregnant women attending one unit of
primary medical care in Botucatu, Brazil, from May 2010 to April
2011, for routine Pap smear screening were candidates for
enrollment in the study. Before the standard pelvic examination,
all women were informed about the aims of the study and signed a
consent term. This study was approved by the Ethics Committee
Board at the Botucatu Medical School (Protocol 2936/2008).
Women were not sampled if they presented one of the following
conditions: vaginal bleeding, use of systemic antibiotic or vaginal
medication during the last 30 days, or having had sexual
intercourse or any vaginal procedure in the preceding 72 h.
After inserting a non-moisturized speculum, two smears from
the mid-lateral vaginal wall were taken. Vaginal pH was measured
using pH strips (range 4.0–7.0, Merck, Germany), by pressing
against the vaginal wall. The whiff test was performed by adding
10% KOH on the sampled swab and results were categorized as
positive, negative or doubtful. Vaginal rinsing with 3 mL of sterile
0.9% NaCl solution was performed with a sterile plastic pipette
allowing contact of the solution with the vaginal wall. The
professionals in charge of the sampling procedures were trained on
how to perform the rinsing and instructed to recover exactly 3 mL.
Samples containing volumes with less than 3 mL or with blood
were discarded. The vaginal rinse samples were centrifuged
(800  g, 10 min) and pellet and supernatant were stored
separately at 20 8C
Cervical samples were taken using a cytobrush to test for
Chlamydia trachomatis and Neisseria gonorrhoeae infection by
polymerase chain reaction (PCR) [20,21]. For detection of
Trichomonas vaginalis, vaginal vault samples were taken with an
Ayre’s spatula, spread on a microscope slide and after adding a
drop of saline immediately examined under 400 magniﬁcation
with a light microscope (Olympus CX31, Tokyo, Japan).
Microscope slides were prepared by adding a drop of 0.9% NaCl
and a cover slip to each swab smear for observation at 400
magniﬁcation in a phase-contrast microscope (Olympus BX41,
Tokyo, Japan). The protocol for classiﬁcation of the vaginal ﬂora
was performed according to Donders et al. [8]. Lactobacillary
grades (LBG) were classiﬁed as LBG I, IIa, IIb or III depending on the
balance between quantity of Lactobacillus morphotypes and other
bacteria found in the smears. The LBG I category reﬂected the
predominance of Lactobacillus sp. morphotypes and was consid-
ered as normal ﬂora. In LBG IIa, smears presented a normal
lactobacillary pattern but a with signiﬁcant quantity of non-
Lactobacillus sp. morphotypes, while in LBG IIb the non-lactoba-
cillary ﬂora exceeded the quantity of Lactobacillus sp although they
were still seen. Finally the smears showing total replacement of
lactobacilli by other microorganisms were classiﬁed as LBG III and
further diagnosed as BV, AV or even mixed infections. Bacterial
vaginosis was diagnosed if its typical granular anaerobe microﬂora
were found on the smear, while AV was deﬁned as the presence of
small bacilli and/or cocci in pairs or chains, taking into account the
lactobacillary grade, ratio of leukocytes to epithelial cells, presence
of toxic leukocytes, and parabasal cells. Candidiasis was identiﬁedwhen unequivocal pseudohyphae and/or blastophores were
detected on the smears.
Interleukin-1b, IL-6, IL-8 and TNF-a concentrations in the
supernatants were quantiﬁed by ELISA with Duo Set Kits (R&D
Systems, Minneapolis, MN). All the samples were tested in
duplicate, and if the concentration was beyond the standard curve
range, the sample was diluted (1:5 and 1:10) and tested again.
Intra-assay variability was <10.0% for IL-1b, IL-6, and IL-8 and
21.4% for TNF-a. Inter-assay variability was 10.0% for IL-1b, 0.15%
for IL-6, 4.5% for IL-8 and 23.0% for TNF-a. The minimum
detectable levels for IL-1b, IL-6, IL-8 and TNF-a assays were,
respectively, 0.4 pg/mL, 4.7 pg/mL, 15.6 pg/mL and 0.23 pg/mL.
Sialidase activity in the rinse supernatants was assayed
quantitatively using the ﬂuorogenic substrate 2-(4-methylumbel-
liferyl)-a-D-N-acetylneuraminic acid (MUAN; Sigma–Aldrich, St.
Louis, MO), as previously described [22]. In a 96-well plate
(OptiPlate-96F, PerkinElmer, Waltham MA), 50 mL of each
supernatant was added to 50 mL of 0.35% MUAN (wt/vol) in
3 mM sodium acetate (pH 4.5) and incubated for 30 min at 37 8C.
The ﬂuorescence was measured at 450 nm, using 365 nm
excitation and 420 nm cutoff ﬁlters in an Epoch spectroﬂuorome-
ter with Gene5 software (Biotek, Winooski VT). The positive
controls were dilutions from 1000.0 ng/mL to 1.0 ng/mL of puriﬁed
Clostridium perfringens neuraminidase (Sigma–Aldrich, St. Louis,
MO), from which the unknown values were interpolated. A
negative control consisting of a sample previously heated at 95 8C
for 20 min, and a sialidase-positive control sample with visible
ﬂuorescence on UV transilluminator, were run in every assay. All
samples were tested in duplicate.
Cytokine and sialidase levels among the groups were compared
with Kruskal–Wallis analysis of variance by ranks, followed by the
Dunn’s multiple comparison post-test when group effects were
signiﬁcant. All statistical tests were performed using GraphPad
Prism 5.0 software (GraphPad, San Diego, CA) and P < 0.05 was
considered as signiﬁcant.
3. Results
Among the 682 candidates for inclusion in the study, we
excluded 166 women that tested PCR-positive for C. trachomatis
(n = 161, 23.5%) and/or N. gonorrhoeae (n = 8, 1.2%). From the group
that tested negative for both pathogens (n = 516), those with
microscopic ﬁnding of candidosis (n = 44, 8.6%), LBGIIa or IIb
(n = 50, 9.7%), cytolitic vaginosis (n = 2, 0.4%), mixed AV and BV
(n = 5, 1.0%) or whose smears were inadequate for microscopic
analysis (n = 7, 1.3%) were also excluded from the study. We
included the remaining 408 women, of whom 285 had normal
ﬂora, 98 had microscopic ﬁnding of full BV, and 25 had moderate or
severe AV. Demographic and gynecological characteristics from
the included women are summarized in Table 1. The population
was homogeneous as none of those variables differed among the
groups, except that years at school approval was signiﬁcantly
lower in the BV group than the normal ﬂora group (P = 0.01).
Vaginal pH was signiﬁcantly increased in abnormal vaginal ﬂora
when compared to the control group.
The cytokine and sialidase levels were measured in all women
with BV and AV included in the study. From the normal ﬂora group,
we evaluated samples from the ﬁrst consecutive 100 women, in
order to equal the sample size of the biggest group presenting
abnormal vaginal ﬂora (BV, n = 98). The levels of IL-1b, IL-6, IL-8
and TNF-a are shown in Fig. 1. Interleukin 1b was detectable in
77.0%, 96.0%, and 92.9% women with normal ﬂora, AV and BV,
respectively. Interleukin-1b concentrations were signiﬁcantly
higher in women with AV (median 178.8 pg/mL; range 0.0–
656.3) and BV (median 71.2 pg/mL; range 0.0–1950.0) when
compared to women with normal ﬂora (median 5.0 pg/mL; range
Table 1
Demographic, behavioral and gynecological characteristics from women included in the study.
Subjects characteristics Normal ﬂora (n = 285) Aerobic vaginitis (n = 25) Bacterial vaginosis (n = 98) P
Age, median (range), years 29 (18–52) 32 (18–50) 33 (18–53) 0.08y
Ethnicity (self-deﬁned), n (%)
White 197/272 (72.4) 18/23 (78.3) 54/85 (63.5)
Nonwhite 75/272 (27.6) 5/23 (21.7) 31/85 (36.5) 0.20z
Education, years, median (range) 11 (0–18)b 8 (4–16)ab 8 (0–16)a 0.01y
Marital status, n (%)
Single 76/275 (27.6) 7/23 (30.4) 32/96 (33.3)
Married 199/275 (72.4) 16/23 (69.6) 64/96 (66.7) 0.57z
Sexually active, n (%) 267/275 (97.1) 21/24 (87.5) 93/96 (96.9) 0.06z
Steady partner (among sexually active only), n (%) 241/267 (90.3) 16/21 (76.2) 85/93 (91.4) 0.10z
Smoking habit, n (%) 58/275 (19.8) 6/24 (25.0) 26/95 (32.6) 0.44z
Contraceptive use, n (%) 108/247 (43.7) 12/22 (54.5) 39/89 (43.8) 0.61z
Type of contraception, n (%)
Oral 62/108 (57.4) 3/12 (25.0) 21/39 (53.8)
Injection 4/108 (3.7) 2/12 (16.7) 3/39 (7.7)
Condom 18/108 (16.7) 5/12 (41.7) 10/39 (25.6)
Intrauterine device 3/108 (2.8) 2/12 (16.7) 4/39 (10.3) NC*
Vaginal pH, median (range) 4.4 (4.0–4.7)a 5.0 (4.4–5.8)b 5.0 (4.0–7.0)b <0.0001y
Total of women may vary among the categories, as some of the data were unavailable or due to patient’s refusal to answer. Different letters in superscript following values
indicate statistical signiﬁcance.
* Not calculated as women may had reported use of more than one method of contraception.
y Kruskal–Wallis with Dunn’s post-test.
z Chi-squared test.
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limit in most of normal (82.0%) and BV samples (69.4%) but only in
28.0% of AV group. Women with AV had signiﬁcantly increased
vaginal IL-6 (median 14.0 pg/mL; range 0.0–735.1) compared to
normal (median 0.0 pg/mL; range 0.0–156.1) and BV (median
0.0 pg/mL; range 0.0–73.3). Interleukin-8 was detected in 92
women with normal ﬂora, 24 with AV and 87 with BV, with levels
increased in AV (median 517.9 pg/mL; range 0.0–2744.0)
as compared to the normal (median 184.3 pg/mL; rangeFig. 1. Cytokine levels in vaginal wash samples from women with normal (n = 1000.0–1985.0) and BV (median 195.6 pg/mL; range 0.0–2200.0). As
shown in Fig. 1, only a few samples had detectable levels of TNF-a:
20.0%, 12.0% and 11.2% from normal, AV and BV, respectively, with
no differences among the groups (P > 0.05).
Sialidase activity was detected in 16 women from the AV group
(64.0%) and 72 (73.5%) from the BV group. Only two of 100 women
with normal ﬂora had detectable sialidase activity. As shown in
Fig. 2, both groups with abnormal vaginal ﬂora had increased
sialidase activity when compared to normal ﬂora.), AV (n = 25) and BV (n = 98) ﬂora. Horizontal bars represent median values.
Fig. 2. Sialidase levels in vaginal wash samples from women with normal (n = 100),
AV (n = 25) and BV (n = 98) ﬂora. Horizontal bars represent median values.
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There is an increasing interest in establishing the microbiolog-
ical and immunological proﬁles of abnormal vaginal ﬂora, since it
has been widely associated with several adverse gynecological and
obstetric conditions [1,4,5]. More recently, several authors have
pointed out that abnormal vaginal ﬂora should no longer continue
to be seen as a single, homogeneous entity, as a great diversity in
the bacterial core and inﬂammatory response is encountered in the
vaginal environment [8,23]. Many characteristics of each type of
ﬂora abnormality and their repercussions on women’s health still
remain to be elucidated, however. In this study, although
education level was signiﬁcantly lower in women with BV, which
is a known factor linked to this type of abnormal vaginal ﬂora [24],
we did not observe any further association of demographic data
with vaginal ﬂora pattern. Several authors have shown that factors
such as smoking habit, ethnicity, and multiple sex partners are
associated with BV, but those studies evaluated a much larger
population than ours [24–26]. In relation to the cytokine and
sialidase ﬁndings, we demonstrated that besides the classical
anaerobic BV, AV can also be considered as a likely candidate to
provoke intense local immunologic changes, as well as an
associated increase in the bacterial sialidase activity, a recognized
risk factor for preterm birth [16,27].
Although BV is not deﬁned as an inﬂammatory condition, IL-1b
is found in particularly high levels in the vagina of women with BV
when compared to pregnant [7,9] and non-pregnant women with
normal ﬂora [8,12], strongly agreeing with the current ﬁndings.
Regarding IL-1b in AV, it has been reported [8] that women with
AV have signiﬁcantly higher vaginal levels than women with BV,
but we found a signiﬁcant increase only when compared to the
normal ﬂora group. When pregnant women were excluded from
the prior analysis [8], however, IL-1b increased equally in both BV
and AV conditions when compared to normal ﬂora.
The current report shows that AV is a condition associated with
the full activation of the inﬂammatory cascade. Unchanged IL-6
concentration in cervical samples [7] and vaginal rinses [8,9] has
been reported in women with BV in relation to normal controls,
while IL-6 showed highly increased levels in AV compared to both
BV and normal ﬂora [8]. Our data are in full agreement with those
ﬁndings regarding IL-6, reinforcing the idea that abnormal vaginal
ﬂora do not behave as a homogeneous group in terms of modifying
the host’s immune response. No previous studies have evaluated
IL-8 in AV, but our data show strongly increased IL-8 concentra-
tions in AV. This should not come as a surprise, given the inﬂux of
leucocytes observed microscopically in cases with moderate and
severe AV [8]. We also found that IL-8 levels remained unchanged
in BV. As IL-8 is a potent neutrophil chemotactic factor, and BV isnot associated with increases in neutrophil counts, higher IL-8
levels are not to be expected in cases of BV [12], but the reason for
this typical non-inﬂammatory response in the presence of so many
potential pathogens still has not been elucidated. TNF-a is
normally found in low, even undetectable, levels in most of
cervicovaginal samples with or without BV [7,28], as supported by
the present study.
We detected sialidase activity in almost 75% of women with BV,
which is similar to previous studies [14,17] even though different
methodologies for sialidase detection were used. To our knowl-
edge, this is the ﬁrst study to evaluate the level of sialidase in a
condition like AV. The ﬁnding of elevated sialidase activity in 64%
of AV cases, a prevalence similar to that in cases of BV, conﬁrms our
understanding that AV should also be considered a potentially
serious condition in pregnancy, because former studies [16,27]
showed that the presence and amount of this bacterial enzyme is
predictive of poor gestational outcome. Because AV cultures yield
aerobes more frequently than BV, it has been proposed that such
species occupy a larger portion of the local ﬂora differently from
BV, which is mostly composed of anaerobes [8]. Additionally, the
sialidase-producer Gardnerella vaginalis can be recovered in only
20% of AV samples [8], and therefore an alternative source of this
enzyme is very likely in AV. One study that focused on the
correlation between the sialidase and cytokine levels in BV showed
a positive correlation of sialidase with IL-1b, but not with IL-8
levels [29]. Those investigators suggested a possible participation
of this enzyme in attenuating the downstream production of
cytokines in BV after IL-1b release, leading to unchanged IL-8
levels and low neutrophil counts, based on the ﬁnding of inverse
correlation of sialidase levels with the IL-8/IL-1b ratio. This seems
unlikely, however, considering that BV itself is associated with
high sialidase and IL-1b levels, but with unchanged IL-8. Indeed,
the combination of high IL-8 levels and sialidase activity in AV
opposes the idea that microbial sialidases can interfere with the
cytokine cascade leading to diminished IL-8 levels. Thus, the
reason for unchanged IL-8 levels in BV, despite the increase in IL-
1b, remains undetermined. Recent work [18] showing that
sialidase promotes proteolysis of IgA illustrates how this bacterial
product may be linked to persistence of abnormal vaginal ﬂora and
its consequences.
We suggest that the great diversity in microbial composition in
abnormal vaginal ﬂora is more important than sialidase alone in
modulating the host’s inﬂammatory response. Taking into account
the importance of bacterial synergism in this environment, further
studies are essential to establish what role alterations in the
vaginal microbiota play in the activation of the immune response
and how they are related to gynecological and obstetric
complications.
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